Is the repair of microbiotic imbalance the beginning of the story of cardiorenal protection?

The human microbiota is a community of bacteria, archaea, fungi, viruses and parasites that form an ecosystem consisting of approximately 1014 microorganisms. The diversity of this community is due to differences in the host’s genome and the influence of environmental factors, including hygiene, diet, lifestyle and the use of various drugs. Research work in the recent past has confirmed that the altered composition of the gut microbiota, dysbiosis, contributes to the development of various diseases, including cardiovascular, type 2 diabetes, chronic kidney disease, metabolic dysfunction-associated steatotic liver disease (MASLD), (formely non-alcoholic fatty liver disease, NASH), chronic inflammatory bowel disease and even some types of cancer. In the article, the author present some modern knowledge about the diverse composition of the human intestinal microbiota, its alterations, dybiosis, and the possibilities of changing the microbiota in the future.